Morpholino

MO2-sulf2a

ID

ZDB-MRPHLNO-200123-1

Name

MO2-sulf2a

Previous Names

None

Target

sulf2a (1)

Sequence

5' - CCATGACCTTAACCAGTGCTCCACC - 3'

Disclaimer

Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.

Note

Translation-blocking MO.

Genome Resources

None

Target Location

Genomic Features

No data available

Expression

Gene expression in Wild Types + MO2-sulf2a

Expressed Gene	Anatomy	Figures
sulf1	whole organism	Fig. 2 from Schenk et al., 2019
sulf2b	whole organism	Fig. 2 from Schenk et al., 2019

Phenotype

Phenotype resulting from MO2-sulf2a

Phenotype	Fish	Figures
caudal artery morphology, abnormal	zf3202Tg + MO2-sulf2a	Fig. 1 from Schenk et al., 2019
caudal fin curved, abnormal	lri500Tg + MO2-sulf2a	Fig. 2 from Schenk et al., 2019
caudal fin intersegmental vessel morphology, abnormal	zf3202Tg + MO2-sulf2a	Fig. 1 from Schenk et al., 2019
glomerular filtration process quality, abnormal	lri500Tg + MO2-sulf2a	Fig. 2 from Schenk et al., 2019
optic choroid vascular plexus EGFP expression decreased amount, abnormal	lri500Tg + MO2-sulf2a	Fig. 2 from Schenk et al., 2019
pericardium edematous, abnormal	lri500Tg + MO2-sulf2a	Fig. 2 from Schenk et al., 2019
post-vent vasculature morphology, abnormal	WT + MO2-sulf2a	Fig. 1 from Schenk et al., 2019
pronephric glomerular basement membrane structure, abnormal	WT + MO2-sulf2a	Fig. 3 from Schenk et al., 2019
pronephric glomerulus morphology, abnormal	WT + MO2-sulf2a	Fig. 3 from Schenk et al., 2019
pronephric podocyte morphology, abnormal	WT + MO2-sulf2a	Fig. 3 from Schenk et al., 2019
whole organism sulf2b expression increased amount, abnormal	WT + MO2-sulf2a	Fig. 2 from Schenk et al., 2019
whole organism sulf1 expression increased amount, abnormal	WT + MO2-sulf2a	Fig. 2 from Schenk et al., 2019
yolk edematous, abnormal	lri500Tg + MO2-sulf2a	Fig. 2 from Schenk et al., 2019

Phenotype of all Fish created by or utilizing MO2-sulf2a

Phenotype	Fish	Conditions	Figures
pronephric glomerular basement membrane structure, abnormal	WT + MO2-sulf2a	control	Fig. 3 from Schenk et al., 2019
whole organism sulf2b expression increased amount, abnormal	WT + MO2-sulf2a	control	Fig. 2 from Schenk et al., 2019
post-vent vasculature morphology, abnormal	WT + MO2-sulf2a	control	Fig. 1 from Schenk et al., 2019
pronephric glomerulus morphology, abnormal	WT + MO2-sulf2a	control	Fig. 3 from Schenk et al., 2019
pronephric podocyte morphology, abnormal	WT + MO2-sulf2a	control	Fig. 3 from Schenk et al., 2019
whole organism sulf1 expression increased amount, abnormal	WT + MO2-sulf2a	control	Fig. 2 from Schenk et al., 2019
yolk edematous, abnormal	lri500Tg + MO2-sulf2a	control	Fig. 2 from Schenk et al., 2019
pericardium edematous, abnormal	lri500Tg + MO2-sulf2a	control	Fig. 2 from Schenk et al., 2019
caudal fin curved, abnormal	lri500Tg + MO2-sulf2a	control	Fig. 2 from Schenk et al., 2019
glomerular filtration process quality, abnormal	lri500Tg + MO2-sulf2a	control	Fig. 2 from Schenk et al., 2019
optic choroid vascular plexus EGFP expression decreased amount, abnormal	lri500Tg + MO2-sulf2a	control	Fig. 2 from Schenk et al., 2019
caudal fin intersegmental vessel morphology, abnormal	zf3202Tg + MO2-sulf2a	control	Fig. 1 from Schenk et al., 2019
caudal artery morphology, abnormal	zf3202Tg + MO2-sulf2a	control	Fig. 1 from Schenk et al., 2019
pronephric glomerular basement membrane structure, abnormal	WT + MO1-sulf2b + MO2-sulf2a + MO4-sulf1	control	Fig. 3 from Schenk et al., 2019
pronephric glomerulus morphology, abnormal	WT + MO1-sulf2b + MO2-sulf2a + MO4-sulf1	control	Fig. 3 from Schenk et al., 2019
pronephric podocyte morphology, abnormal	WT + MO1-sulf2b + MO2-sulf2a + MO4-sulf1	control	Fig. 3 from Schenk et al., 2019

Citations